12 Medical Devices Stocks to Buy Now

HTWR, ELGX, NEOG, BCR, CPTS, ARTC, SMA, THOR, CUTR, IMRS, WWIN, TEAR improve in weekly rankings

   
12 Medical Devices Stocks to Buy Now

This week, 12 Medical Devices stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

This week, HeartWare International (NASDAQ:HTWR) is showing significant improvement as the company’s rating hops from a C (“hold”) to a B (“buy”). HeartWare International is developing a range of implantable mechanical circulatory assist devices or heart pumps, used for the treatment of congestive heart failure. For more information, get Portfolio Grader’s complete analysis of HTWR stock.

This week, Endologix’s (NASDAQ:ELGX) ratings are up from a C last week to a B. Endologix develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. For more information, get Portfolio Grader’s complete analysis of ELGX stock.

Neogen Corp. (NASDAQ:NEOG) improves from a C to a B rating this week. Neogen develops and markets products and services dedicated to food and animal safety. For more information, get Portfolio Grader’s complete analysis of NEOG stock.

C.R. Bard (NYSE:BCR) is seeing ratings go up from a C last week to a B this week. C. R. Bard is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. For more information, get Portfolio Grader’s complete analysis of BCR stock.

Conceptus (NASDAQ:CPTS) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Conceptus designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and rest of Europe. For more information, get Portfolio Grader’s complete analysis of CPTS stock.

ArthroCare (NASDAQ:ARTC) shows solid improvement this week. The company’s rating rises from a C to a B. ArthroCare is a multi-business medical device Company that develops, manufactures and markets minimally invasive surgical products, many of which are based on its patented Coblation(r) technology. For more information, get Portfolio Grader’s complete analysis of ARTC stock.

The rating of Symmetry Medical (NYSE:SMA) moves up this week, rising from a C to a B. Symmetry Medical provides global orthopedic device manufacturers with implants and related instruments and cases. For more information, get Portfolio Grader’s complete analysis of SMA stock.

Thoratec (NASDAQ:THOR) boosts its rating from a C to a B this week. Thoratec is involved in the development, manufacture and marketing of proprietary medical devices used for circulatory support. For more information, get Portfolio Grader’s complete analysis of THOR stock.

This is a strong week for Cutera (NASDAQ:CUTR). The company’s rating climbs to B from the previous week’s C. Cutera is a global provider of laser and other light-based aesthetic systems for practitioners worldwide. Shares of CUTR have increased 18.6% over the past month, better than the 7.2% decrease the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of CUTR stock.

This week, IMRIS Inc. (NASDAQ:IMRS) pushes up from a C to a B rating. IMRIS is a medical imaging company that focuses on bringing magnetic resonance imaging (MRI) to surgical procedures. For more information, get Portfolio Grader’s complete analysis of IMRS stock.

Winner Medical Group (NASDAQ:WWIN) boosts its rating from a B to a A this week. Winner Medical Group engages in the research, development, manufacture, and marketing of cotton-base medical dressings and medical disposables. For more information, get Portfolio Grader’s complete analysis of WWIN stock.

This week, TearLab (NASDAQ:TEAR) pushes up from a B to a A rating. TearLab is an in-vitro diagnostics company. For more information, get Portfolio Grader’s complete analysis of TEAR stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2012/11/12-medical-devices-stocks-to-buy-now-htwr-elgx-neog/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.